ROHAN PALEKAR - 01 Feb 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol
ETNB
Transactions as of
01 Feb 2024
Transactions value $
-$49,666
Form type
4
Filing time
05 Feb 2024, 20:16:12 UTC
Previous filing
18 Jan 2024
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +150K +43.02% $0.00 499K 01 Feb 2024 Direct F1
transaction ETNB Common Stock Tax liability -$49.7K -5.07K -1.02% $9.80 494K 05 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +605K $0.00 605K 01 Feb 2024 Common Stock 605K $9.98 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
F3 This option represents a right to purchase a total of 605,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.